Melike KOÇOĞLU KALKAN, Sevde Nur BİLTEKİN KALELİ, Leyla YURTTAŞ, Şeref DEMİRAYAK, Zafer ŞAHİN, Barkın BERK, Ceysu BENDER

Synthesis, characterization, COX1/2 inhibition and molecular modeling studies on novel 2-thio-diarylimidazoles

Heterocyclic compounds with diaryl substituents have been a milestone approach for selective cyclooxygenase 2 (COX 2) inhibition by bioisosteric replacements and modifications. It is also known that thiazole derivatives have different pharmacological activities. In this study, nine novel 2-[(1,5-diphenyl-1H-imidazole-2-yl)thio]-N-(thiazole-2-yl)acetamide derivatives (Compound 1-9) were synthesized via the reaction of 1,5-disubstitued phenyl-imidazole-2-thiole and N-thiazole acetamide. The inhibitory effects of COX-1 and COX-2 enzymes were tested for the synthesized compounds. Enzyme-ligand interactions of the most active compound on COX subtypes were elucidated by molecular modeling studies. The percent inhibitory effect for compound 1, which is the naked derivative among all the compounds, was found to be the most active on COX-2 at 10 μM concentration $(C1_{COX-2}: 88%, SC-560_{COX-2}: 98.2%, C1_{COX-1}: 60.9%)$; whereas compound 9 showed the highest inhibitory effect and was found to be the most selective derivative on COX-1 isoenzyme $(C9_{COX-1}: 85%, DuP-697_{COX-1}: 97.2%, C9_{COX-2}: 57.9%)$.

PDF

___

1. Kwon J, Kim MJ, Kim DC, Kwon H, Ryu SM et al. Anti-inflammatory spiroditerpenoids from Penicillium bialowiezense. Bioorganic Chemistry 2021; 113:105012. doi: 10.1016/j.bioorg.2021.105012
2. Yarla NS, Pathuri G, Gali H, Terzyan S, Panneer S et al. Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases. Journal of Inflammation Research 2020; 31 (13): 1261-1278. doi: 10.2147/ JIR.S286110
3. Murphy RC, Hammarström S, Samuelsson B, Leukotriene C. A slow-reacting substance from murine mastocytoma cells. Proceedings of the National Academy of Sciences of the United States of America 1979; 76 (9): 4275-4279. doi: 10.1073/pnas.76.9.4275
4. Allaj V, Guo C, Nie D. Non-steroid anti-inflammatory drugs, prostaglandins, and cancer. Cell Bioscience 2013; 3: (8). doi: 10.1186/2045- 3701-3-8
5. Kawamori T, Rao CV, Seibert K, Reddy BS. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Research 1998; 58 (3): 409-412.
6. Katori M, Majima M. Cyclooxygenase-2: Its rich diversity of roles and possible application of its selective inhibitors. Inflammation Research 2000; 49 (8): 367-392.
7. Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflammation Research 1998; 47: 78-87. doi: 10.1007/ s000110050605
8. Patrono C. Cardiovascular effects of cyclooxygenase-2 inhibitors: a mechanistic and clinical perspective. British Journal of Clinical Pharmacology 2016; 82 (4): 957–964. doi: 10.1111/bcp.13048
9. Chen CS, Tan CM, Huang CH, Chang LC, Wang JP. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2] dithiazoliumylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-α production. Bioorganic & Medicinal Chemistry 2010; 18 (2): 597-604. doi: 10.1016/j.bmc.2009.12.008
10. Saberi MR, Hadizadeh F, Imenshahidi M, Shakeri H, Toktam S et al. Synthesis and Effects of 4,5-Diaryl-2-(2-alkylthio-5-imidazolyl) Imidazoles as Selective Cyclooxygenase Inhibitors. Science 2010; 13 (4): 225-231. doi: 10.22038/IJBMS.2010.5121
11. Dinges J, Harris CM, Wallace GA, Argiriadi MA, Queeney KL et al. Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors. Bioorganic & Medicinal Chemistry Letters 2016; 26 (9): 2297–2302. doi: 10.1016/j.bmcl.2016.03.043
12. Pandeya SN, Bipin B, Aparna M, Ashish B. Synthesis and analgesic activity of 2-S-benzyl-1,5-diphenyl-1H imidazoles. Journal of Scientific Research in Pharmacy 2012; 1 (3): 19-22.
13. Demirayak S, Kayagil I, Yurttas L, Aslan R. Synthesis of some imidazolyl-thioacetyl-pyrazolinone derivatives and their antinociceptive and anticancer activities. Journal of Enzyme Inhibition and Medicinal Chemistry 2009; 25 (1): 74-79. doi: 10.3109/14756360903016751
14. Papadopoulou C, Geronikaki A, Hadjipavlou-Litina D. Synthesis and biological evaluation of new thiazolyl/benzothiazolyl-amides, derivatives of 4-phenyl-piperazine. Farmaco 2005; 60 (11–12): 969-973. doi: 10.1016/j.farmac.2005.06.014
15. Kaur A, Wakode S, Pathak DP, Sharma V, Shakya AK. Synthesis, cyclooxygenase-2 inhibition, anti-inflammatory evaluation and docking study of substituted-N-(3,4,5-trimethoxyphenyl)-benzo[d]oxazole derivatives. Medicinal Chemistry 2018; 14 (7): 660-673. doi: 10.2174/ 1573406414666180322091832
16. Chegaev K, Lazzarato L, Tosco P, Cena C, Marini E et al. NO-donor COX-2 inhibitors. New nitrooxy-substituted 1,5-diarylimidazoles endowed with COX-2 inhibitory and vasodilator properties. Journal of Medicinal Chemistry 2007; 50 (7): 1449-1457. doi: 10.1021/ jm0607247
17. Assadieskandar A, Amirhamzeh A, Salehi M, Ozadali K, Ostad S et al. Synthesis, cyclooxygenase inhibitory effects, and molecular modeling study of 4-aryl-5-(4-(methylsulfonyl)phenyl)-2-alkylthio and -2-alkylsulfonyl-1H- imidazole derivatives. Bioorganic & Medicinal Chemistry 2013; 21 (8): 2355-2362. doi: 10.1016/j.bmc.2013.01.058
18. Chavatte P, Yous S, Marot C, Baurin N, Lesieur D. Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: A comparative molecular field analysis. Journal of Medicinal Chemistry 2001; 44 (20): 3223-3230. doi: 10.1021/ jm0101343
19. Chen H, Li Q, Yao X, Fan BT, Yuan S et al. CoMFA/CoMSIA/HQSAR and Docking study of the binding mode of selective cyclooxygenase (COX-2) inhibitors. QSAR Combinatorial Science 2004; 23 (1): 36-55. doi: 10.1002/qsar.200330844
20. Zarghi A, Arfaei S, Ghodsi R. Design and synthesis of new 2,4,5-triarylimidazole derivatives as selective cyclooxygenase (COX-2) inhibitors. Medicinal Chemistry Research 2012; 21 (8): 1803-1810. doi: 10.1007/s00044-011-9710-5
21. Santosa H, Yuniarta TA, Kesuma D, Putra GS (2019). 2-Hydroxy-N′-(4-Fluorobenzoyl)Benzohydrazide. Molbank, 2020 (1): M1103. doi:10.3390/m1103.
22. Abdel-Sayed MA, Bayomi SM, El-Sherbeny MA, Abdel-Aziz NI, ElTahir KEH et al. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives. Bioorganic & Medicinal Chemistry 2016; 24 (9): 2032-2042. doi: 10.1016/j.bmc.2016.03.032
23. Qandeel NA, El-Damasy AK, Sharawy MH, Bayomi SM, El-Gohary NS. Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophenes. Bioorganic Chemistry 2020; 103890. doi: 10.1016/j.bioorg.2020.103890
24. Abdellatif KRA, Fadaly WAA, Elshaier YAM, Ali WAM, Kamel GM. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Bioorganic Chemistry 2018; 77: 568-578. doi:10.1016/j.bioorg.2018.02.018
25. Abdel-Sayed MA, Bayomi SM, El-Sherbeny MA, Abdel-Aziz NI, ElTahir KEH et al. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibition activities and molecular docking study of pyrazoline derivatives. Bioorganic & Medicinal Chemistry 2016; 24 (9): 2032-2042. doi:10.1016/j.bmc.2016.03.032